Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 178 of 178 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 10/12/09
End: 05/23/17
Due: 05/23/18
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 04/30/14
Due: 04/30/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase I Study of MLN6907 in Patients With Metastatic Colorectal | NCT02056015 | Millennium Pharmaceuticals, Inc. | user2@example.com | None | 2015-06-30 | 2015-09-30 | 2016-09-30 | - | - | 2025-07-14 |
| Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma | NCT00932698 | Millennium Pharmaceuticals, Inc. | user2@example.com | None | 2009-10-12 | 2017-05-23 | 2018-05-23 | - | - | 2025-07-14 |
| A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects | NCT02093390 | Millennium Pharmaceuticals, Inc. | user2@example.com | None | 2014-03-31 | 2014-04-30 | 2015-04-30 | - | - | 2025-07-14 |